IVFhMG 150iu (Menotrophin [HMG])

Introduction

IVFhMG 150 IU is an injectable fertility medicine that contains Menotrophin (Human Menopausal Gonadotropin, also known as HMG). Menotrophin is a hormone purified substance that is typically used to trigger the cycle of ovulation for women who are undergoing fertility treatment such as IVF (IVF) and intrauterine insemination (IUI). Menotrophin mimics the actions of gonadotropins that are naturally produced — Follicle-stimulating Hormone (FSH) and luteinizing hormone (LH), both of which are crucial in follicular growth and the ovulation process.

The article focuses on the drug’s pharmacology, its indications, dosage protocols, adverse reactions, safety measures, as well as the storage and use of IVFhMG 150 IU.

What is Menotrophin (HMG)?

Menotrophin is a combination consisting of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) extracted from the urine of postmenopausal women. The balance of FSH and LH encourages the growth of ovarian follicles, maturation, and the ovulation process.

• FSH is primarily responsible for the maturation and growth of the ovarian follicles.
• LH stimulates ovulation and helps support the corpus luteum function.

As a result of this effect, menotropin is used effectively for controlled ovarian stimulation procedures.

Mechanism of Action

IVFhMG 150 IU works by substituting or enhancing the body’s gonadotropins, which are naturally produced by our bodies:

• FSH component: Enhances the number of granulosa cell types inside ovarian follicles. It also promotes the development of follicular cells and the production of estrogen.
• LH component: Theca cells are stimulated to make androgens. They are precursors to estrogen synthesis. LH helps to promote the maturation of follicular hairs and ovulation.

The stimulation combined results in the formation of many Follicles, which increase the likelihood of fertilization and successful ovulation in assisted reproduction procedures.

Indications

IVFhMG 150 IU stands to be used for:

• Ovulation, also known as anovulation for women who want to have a baby.
• Women who suffer from hypogonadotropic hypergonadism (deficiency in LH as well as FSH).
• Controlled Ovarian hyperstimulation (COH) is used in the IVF cycle to stimulate the development of several Follicles.
• Infertility treatment triggered by hormone imbalance in cases where other treatment options (like Clomiphene citrate) have not worked.
• Infertility in males due to hypogonadotropic hypergonadism (less often used).

Dosage and Administration

Menotrophin can be administered via injections into the intramuscular (IM) or subcutaneous (SC) injection. The dose must be tailored depending on the response of the patient to age, weight, and reserve of ovarian reserve.

Typical IVFhMG Dosing Protocol:

• Starting dose: Most commonly, 75-150 IU each day, which is injected either via SC or IM.
• Adjustments to doses are dependent on the ovarian response as measured by ultrasound and the level of estrogen.
• The length of the treatment may vary between 7 to 14 days until the follicles attain the right dimension (usually 18-20 mm).
• If follicles have matured, human chorionic gonadotropin (hCG) is administered to stimulate ovulation.
• Regular ultrasounds are part of the monitoring program, as are hormonal tests to prevent the overstimulation of the ovaries.

Special Notes:

• Dosage could be less for women suffering from polycystic ovary syndrome (PCOS) to lower the possibility of hyperstimulation.
• Treatment must be conducted with strict medical supervision because of the risk of Ovarian hyperstimulation syndrome (OHSS) as well as multiple pregnancy.

Pharmacokinetics

• Following IM or SC injection, menotrophin becomes absorbed and is circulated to the target ovarian cells.
• The biological half-life is a way to dose once a day.
• The body is metabolized by hormones that exert their influence principally via receptor binding.

Side Effects

Common Side Effects:

• Injection site reactions (pain, redness, swelling).
• Abdominal discomfort or bloating.
• Headache, fatigue.
• Breast tenderness.
• Mood swings or irritability.

Serious Side Effects:

• Ovarian Hyperstimulation Syndrome (OHSS): An extremely life-threatening disorder that is characterised by enlarged ovaries, an accumulation of fluid in the chest and abdomen, and imbalances in electrolytes.
• Multiple pregnancies: More likely to have twins or higher-order multiples, which can lead to a more risky pregnancy.
• Allergic reactions (rare): Rash, itching, swelling, difficulty breathing.
• Thromboembolic events (rare).

Precautions and Warnings

• Make use of IVFhMG only when under the supervision of a qualified specialist.
• Examine ovarian response carefully for a reduction in OHSS risk.
• Beware of using this product in women who have an adrenal disorder or thyroid disorder that is not controlled.
• It is not recommended to take part in nursing or during pregnancy.
• Beware of women who have bladder cysts or ovarian growth.
• Stop treatment if severe side effects develop.

Contraindications

• Primary ovarian failure.
• Instability of thyroid hormones or adrenal disorders.
• Pregnancy.
• Ovarian cysts are not connected to polycystic-ovary syndrome.
• Hormone-dependent cancers that are hormone dependent (e.g., breast, Ovarian cancer).
• Hypersensitivity to menotrophin or other excipients.

Drug Interactions

• It is possible to cause interactions with fertility drugs. This requires careful adjustment of the protocol.
• Do not use medications concurrently that can affect the levels of estrogen or affect ovarian function unless a doctor has recommended it.

Monitoring During Treatment

• Transvaginal ultrasounds are performed in series to determine the size of follicles and their number.
• Estradiol levels in serum are used to track the response of the ovaries.
• Be on the lookout for signs that suggest early onset of OHSS.
• Modify dosage or stop the medication.

Storage

• Store refrigerated between 2°C and 8°C (36°F and 46°F).
• Keep your home safe from the elements and freeze.
• Make use of immediately following reconstitution.

Summary

IVFhMG 150 IU (Menotrophin) is an essential medication used in assisted reproduction. It provides an even balance of FSH as well as LH stimulation required to stimulate follicular growth and ovulation. This medication requires specialist management because of the difficulty in dosage and the potential for risks such as OHSS and multiple pregnancy cycles. If properly monitored, IVFhMG significantly improves the chance of achieving ovulation as well as pregnancy among women suffering from diverse types of infertility.